| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $15.9M | -0.9% | -43.8% |
| Cost of Revenue | $13.7M | +0.6% | -38.1% |
| Gross Profit | $2.3M | -9.2% | -63.6% |
| R&D Expense | $0 | — | — |
| SG&A Expense | $3.3M | +1.4% | -7.0% |
| Operating Income | -$1.6M | -17.4% | -181.8% |
| Net Income | -$1.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $13.6M | +9.0% | +10.3% |
| Accounts Receivable | $8.3M | +3.0% | -6.3% |
| Inventory | $4.0M | -4.7% | -32.7% |
| Current Assets | $37.5M | +18.7% | +9.6% |
| Total Assets | $57.5M | +9.2% | +0.7% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.0M | — | — |
| Investing Cash Flow | -$4.4M | — | — |
| Financing Cash Flow | $5.3M | — | — |
| -205.3% |
| EPS (Basic) | -$0.05 | +0.0% | -200.0% |
| EPS (Diluted) | -$0.05 | +0.0% | -225.0% |
| $9.6M |
| -12.5% |
| -32.4% |
| Long-term Debt | $8.7M | +1.0% | +4.2% |
| Total Liabilities | $20.5M | -7.9% | -26.8% |
| Stockholders' Equity | $37.0M | +21.7% | +27.1% |